Toggle navigation
Home
Search
Services
Blog
Contact
About
Center for Addiction and Alternative Medicine Research
Kiresuk, Thomas J.
Minneapolis Medical Research Fdn, Inc., Minneapolis, MN, United States
Search 8 grants from Thomas Kiresuk
Search grants from Minneapolis Medical Research Fdn, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Low-Field High-Performance MRI for Screening Clinically Significant Prostate Cancer
Mechanisms of adverse effects of anti-tuberculosis drugs
Predictors of Smokeless Tobacco and Dual Use in the US Military
DNA gyrase and quinolone resistance in tuberculosis
Antiphospholipid Syndrome Registry (Apscore)-264002248
Recently added grants:
Exploiting Ecology and Evolution to Prevent Therapy Resistance in EGFR-Driven Lung Cancer
Preclinical Time domain Fluorescence Tomography Platform
Afferent renal nerves, renal inflammation, and hypertension
Behavioral outcomes and neurobiological mechanisms of sustained auditory selective attention
Nanoscale organization of the inhibitory synapse during synaptic plasticity
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
1P50HL061193-01
Application #
2719156
Study Section
Special Emphasis Panel (ZRG2-GMA-2 (02))
Project Start
1998-09-01
Project End
2003-06-30
Budget Start
1998-09-01
Budget End
1999-06-30
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
Minneapolis Medical Research Fdn, Inc.
Department
Type
DUNS #
City
Minneapolis
State
MN
Country
United States
Zip Code
55415
Related projects
Publications
Keyler, Daniel E; Dufek, Matthew B; Calvin, Andrew D et al.
(2005)
Reduced nicotine distribution from mother to fetal brain in rats vaccinated against nicotine: time course and influence of nicotine dosing regimen.
Biochem Pharmacol 69:1385-95
Comments
Be the first to comment on Thomas Kiresuk's grant